Complications of beta-thalassemia major in North America.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-09-3167PMID 14988152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Edmonton tackles shaken baby syndrome.

  2003cited by this paper
• Canada will check donor blood for West Nile virus if test available.

  2003cited by this paper
• As West Nile virus season heats up, blood safety testing lags behind.

  2003cited by this paper
• Liver disease in transfusion dependent thalassaemia major

  2002cited by this paper
• Investigations of West Nile virus infections in recipients of blood transfusions.

  2002cited by this paper
• Growth and Puberty and Its Management in Thalassaemia

  2002cited by this paper
• Transfusion-transmitted malaria in the United States from 1963 through 1999.

  2001cited by this paper
• Vertical Transmission of Hepatitis C Virus in a Cohort of 2,447 HIV-Seronegative Pregnant Women: A 24-Month Prospective Study

  2001cited by this paper
• Reducing the risk of blood transfusion.

  2001cited by this paper
• Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders

  2001cited by this paper
• Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia

  2000cited by this paper
• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

  2000cited by this paper
• Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia.

  2000cited by this paper
• The beta-thalassemias.

  1999cited by this paper
• The β-Thalassemias

  1999cited by this paper
• A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia

  1999cited by this paper
• BONE DISEASE IN β‐THALASSAEMIA MAJOR

  1998cited by this paper
• High prevalence of low bone mass in thalassaemia major

  1998cited by this paper
• New Approaches to the Management of Hepatitis and Endocrine Disorders in Cooley's Anemia

  1998cited by this paper
• Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.

  1998cited by this paper
• Survival and Disease Complications in Thalassemia Major

  1998cited by this paper
• Prospective on Thalassemia

  1998cited by this paper
• Iron Chelators for Thalassaemia

  1998cited by this paper
• Pathophysiology of Iron Overload a

  1998cited by this paper
• Bone disease in beta-thalassaemia major.

  1998cited by this paper
• Pioneers and modern ideas. Prospective on thalassemia.

  1998cited by this paper
• Iron-chelating therapy and the treatment of thalassemia.

  1997cited by this paper
• A Risk-Benefit Assessment of Iron-Chelation Therapy

  1997cited by this paper
• Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients

  1997cited by this paper
• Growth, Puberty and Endocrine Function in Beta-Thalassaemia Major

  1997cited by this paper
• Results of long-term iron-chelating therapy.

  1996cited by this paper
• Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

  1994cited by this paper
• Survival in Medically Treated Patients with Homozygous β-Thalassemia

  1994cited by this paper
• Survival in medically treated patients with homozygous beta-thalassemia.

  1994cited by this paper
• Cirrhosis associated with multiple transfusions in thalassaemia.

  1984cited by this paper
• [Beta-thalassemias].

  1983cited by this paper
• The thalassaemia syndromes

  1965cited by this paper
• Transfusion Therapy and its Complications in Patients with Cooley's Anemia

  1964cited by this paper

• Nanozymes in biomedicine: Unraveling trends, research foci, and future trajectories via bibliometric insights (from 2007 to 2024).

  2025cites this paper
• Retinal Complications in a Patient With Pediatric Thalassemia: A Case Report

  2025cites this paper
• Lifetime Risk of Liver Disease in Patients With β‐Thalassemia: Data From the de‐LIGHT Retrospective Cohort Study

  2025cites this paper
• Host Immunogenetics and Chronic HCV Infection Shape Atopic Risk in Pediatric Beta-Thalassemia: A Genotype–Phenotype Study

  2025cites this paper
• The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic Applications

  2025cites this paper
• Special considerations in assisted reproductive technology for patients with hematologic disease.

  2025cites this paper
• An ethical allocation scheme for scarce gene therapies in sickle cell disease and transfusion-dependent β-thalassemia

  2025cites this paper
• Evaluating the effect of chicory on serum ferritin levels in transfusion-dependent Β-thalassemia patients: a randomized clinical trial

  2025cites this paper
• 输血依赖型地中海贫血儿童及青少年体格发育现状调查分析

  2025cites this paper
• Study of Thyroid Function in Children With Beta-Thalassemia Major

  2025cites this paper
• Outcome of Blood Transfusion on Thalassemia Patients

  2025influential citation
• Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre

  2024cites this paper
• Sex and Gender Differences in Iron Chelation

  2024cites this paper
• β-Thalassemia Major Complicated by Acute Myeloid Leukemia

  2024cites this paper
• Talasemias en el niño

  2024cites this paper
• The effect of aqueous extract of Iranian oak (Quercus brantii) on antioxidant capacity and oxidative stress in beta-thalassemia patients: Randomized controlled trial.

  2024cites this paper
• Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing

  2024cites this paper
• Point Shear Wave Elastography Detected Liver Stiffness Increased in Pediatric Patient With Thalassemia Major

  2024cites this paper
• Craniofacial growth Pattern of Thalassemia Major Patients in the haematological institutes of populations of Karachi Pakistan.

  2024cites this paper
• Iron chelators: as therapeutic agents in diseases

  2024cites this paper
• Current Status of β-Thalassemic Burden in India

  2023cites this paper
• Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending

  2023cites this paper
• Assessment of Liver Functions in Thalassaemia

  2023cites this paper
• Thalassemia‐related complications in pediatric, adolescent, and young adult patients with transfusion‐dependent thalassemia: A multicenter study in Thailand

  2023cites this paper
• Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up

  2023cites this paper
• Prevalence and Management of Transfusional Iron Overload in Syrian Beta Thalassemia Major Patients Pre and during the Syrian Conflict

  2023cites this paper
• The Role of Extracellular Vesicles on the Occurrence of Clinical Complications in β-Thalassemia.

  2023cites this paper
• A new approach for the diagnosis of b-thalassemia in archaeological contexts: the relationship between congenital anaemia and dentinogenesis defects through micro-CT

  2023cites this paper
• Thalassémies chez l’enfant

  2023cites this paper
• α- and β-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh

  2023cites this paper
• A Ce-MOF@polydopamine composite nanozyme as an efficient scavenger for reactive oxygen species and iron in thalassemia disease therapy.

  2023cites this paper
• Clinical experience using peripheral blood parameters to analyse the mutation type of thalassemia carriers in pregnant women

  2023cites this paper
• Renal Disease in b-Thalassemia. Is there a Relation to ApoE Gene Polymorphism? A Study in b-Thalassemia Egyptian Patients

  2023cites this paper
• Mortality and complications in Omani patients with beta-thalassemia major: a long-term follow-up study

  2023cites this paper
• A Review on Current Status of Blood Disorder: Thalassemia and its Treatment

  2023cites this paper
• Thalassemia in Indonesia

  2022cites this paper
• Biochemical assessment of renal function and its correlation with iron overloading in different variants of thalassemia

  2022cites this paper
• Prediction of Heart and Liver Iron Overload in β-Thalassemia Major Patients Using Machine Learning Methods

  2022cites this paper
• Genetic predictions of life expectancy in southern Thai patients with β0-thalassemia/Hb E

  2022cites this paper
• Direct sequencing of β-globin gene reveals a rare combination of two exonic and two intronic variants in a β-thalassemia major patient: a case report

  2022cites this paper
• Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation

  2022cites this paper
• Management of Endocrine Complications Affecting Survival and Quality of Life in Children and Adolescents with Thalassemia Major: A Single Center Experience

  2022cites this paper
• Hemoglobinopathies

  2022cites this paper
• Iron-mediated tissue damage in acquired ineffective erythropoiesis disease: It's more a matter of burden or more of exposure to toxic iron form?

  2022cites this paper
• Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron Disorders

  2022cites this paper
• Efektivitas Deferasirox pada Pasien Thalasemia Mayor: Artikel Review

  2022cites this paper
• Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major

  2022cites this paper
• Epidemiologic Trends of Thalassemia, 2006–2018: A Nationwide Population-Based Study

  2022cites this paper
• Outcomes of allogeneic transplantation for hemoglobin Bart’s hydrops fetalis syndrome in Hong Kong

  2021cites this paper
• Heart involvement in transfusion-dependent beta-thalassemia with conventional echocardiography

  2021cites this paper
• Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort

  2021cites this paper
• Skewed intracellular cytokine production of iNKT cells toward Th2-related responses in alloimmunized thalassemia patients.

  2021cites this paper
• Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients

  2021cites this paper
• An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

  2021cites this paper
• AMER International Conference on Quality of Life

  2021cites this paper
• Barriers to Adherence to Iron Chelation Therapy in Thalassemia Patients

  2021cites this paper
• Assessment of the Nutritional Status, Bone Mineralization, and Anthropometrics of Children with Thalassemia Major

  2021cites this paper
• Zinc levels in Beta-Thalassemia Major: A Review of the Literature

  2021cites this paper
• The transfusion management of beta thalassemia in the United States

  2021cites this paper
• Stable Luminescent Poly(Allylaminehydrochloride)-Templated Copper Nanoclusters for Selectively Turn-Off Sensing of Deferasirox in β-Thalassemia Plasma

  2021cites this paper
• Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina

  2020cites this paper
• Thalassemia in Iraq Review Article

  2020cites this paper
• Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq

  2020cites this paper
• Prevalence and risk factors of severe bacterial infections in thalassemia patients.

  2020cites this paper
• Comparison of deferasirox and deferoxamine effect on liver enzyme activities and ferritin level in patients with beta-thalassemia

  2020cites this paper
• The association between pre-transfusion hemoglobin levels and thalassemia complications

  2020cites this paper
• Changing patterns in the epidemiology of β‐thalassemia

  2020cites this paper
• Assessment of cardiac and liver iron overload by magnetic resonance imaging in patients with thalassemia major: short-term follow-up

  2020cites this paper
• Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications

  2020cites this paper
• Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review

  2020cites this paper
• Using LIBS as a diagnostic tool in pediatrics beta-thalassemia

  2020cites this paper
• Splenomegaly may increase the risk of rejection in low risk matched related donor transplant for thalassemia and this risk can be partially overcome by additional immunosuppression during conditioning.

  2020cites this paper
• Endocrine and metabolic disorders in adult patients with thalassemia major

  2020influential citation
• Assessment of Hepatic Iron Overload in Paediatric Beta Thalassemia Major Patients using T2* Weighted Gradient Echo Magnetic Resonance Imaging

  2020cites this paper
• Complications and Challenges in the Management of Iraqi Patients with β-Thalassemia Major: A Single-center Experience

  2020cites this paper
• Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's Disease.

  2020cites this paper
• The effect of deferasirox on endocrine complications in children with thalassemia

  2020cites this paper
• Endocrine complications of beta-thalassemia major patients—Cross-sectional study

  2020cites this paper
• Cu2+-induced quenching and recovery of the luminescence of dopamine-conjugated carbon dots for sensing deferasirox in plasma

  2020cites this paper
• Reproductive health issues in female patients with beta-thalassaemia major: a narrative literature review

  2020cites this paper
• A Study to Assess the Quality of Life amongChildren with Thalassemia and its Relationshipwith Selected Factors in Selected Hospitals of Delhi

  2020cites this paper
• Assessment of ventricular dysfunction in Egyptian children with Beta-thalassemia major.

  2020cites this paper
• Pubertal status and its relation with serum ferritin level in thalassemia major patients

  2019cites this paper
• A nationwide survey of hospital-based thalassemia patients and standards of care and a preliminary assessment of the national prevention program in Sri Lanka

  2019cites this paper
• A “One-Stop” Screening Protocol for Haemoglobinopathy Traits and Iron Deficiency in Sri Lanka

  2019cites this paper
• Oral manifestation of thalassemia  mayor: case study

  2019cites this paper
• STUDY OF THYROID PROFILE IN BETA THALASSEMIA MAJOR CHILDREN OF NORTH BIHAR AND ITS CORRELATION WITH SERUM FERRITIN LEVELS

  2019cites this paper
• Attention, response inhibition and brain event‐related potential alterations in adults with beta‐thalassaemia major

  2019cites this paper
• Cellular adaptation mediated through Nrf2-induced glutamate cysteine ligase up-regulation against oxidative stress caused by iron overload in β-thalassemia/HbE patients

  2019cites this paper
• Fertility in Patients with Thalassemia and Outcome of Pregnancies: A Turkish Experience

  2019cites this paper
• Pregnancy in Thalassemia

  2019cites this paper
• Science 2019 ; ( ) : Skin , hair and nail findings in children with beta-thalassemia

  2019cites this paper
• Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis

  2019cites this paper
• A 1-year randomized trial of deferasirox alone versus deferasirox and deferoxamine combination for the treatment of iron overload in thalassemia major.

  2019cites this paper
• Serum Ferritin Correlated With Deficiency of Serum Vitaminb12 and Folic Acid in Thalassemia

  2019cites this paper
• Insulin secretion-sensitivity index-2 could be a novel marker in the identification of the role of pancreatic iron deposition on beta-cell function in thalassemia major.

  2019cites this paper
• Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study

  2019cites this paper
• The Cutoff of Ferritin for Evaluation of Hypothyroidism in Patients With Thalassemia

  2019cites this paper
• Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography

  2018cites this paper
• Iron Chelation Therapy as a Modality of Management.

  2018cites this paper